Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia

Journal of Clinical Investigation

Volumn 104, Issue 9, 1999, Pages 1307-1317

  Wright, Terry W ^a,c   Gigliotti, Francis ^a   Finkelstein, Jacob N ^a   McBride, John T ^a   An, Chun Li ^b   Harmsen, Allen G ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b TRUDEAU INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING RATE; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; INFLAMMATION; LUNG COMPLIANCE; LUNG FUNCTION; LUNG INJURY; MOUSE; NONHUMAN; PATHOGENESIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE OXYGENATION;

EID: 0032725183     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6688     Document Type: Article

References (29)

1. Su, T.H., and Martin, W.J. II. 1994. Pathogenesis of host response in Pneumocystis carinii pneumonia. Annu. Rev. Med. 45:261-272.
2. Sepkowitz, K.A. 1993. Pneumocystis carinii pneumonia in patients without AIDS. Clin. Inf. Dis. 17(Suppl. 2):S41-S422.
3. CDC. 1989. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with Human Immunodeficiency Virus. MMWR Morb. Mortal. Wkly. Rep. 38:(Suppl. 5):1-9.
4. Kovacs, J.A., et al. 1984. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann. Intern. Med. 100:663-671.
5. Benfield, T.L., et al. 1995. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med. 151:1058-1062.
6. Limper, A.H., Offord, K.P., Smith, T.F., and Martin, W.J., II. 1989. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140:1204-1209.
7. The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia. 1990. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the Acquired Immunodeficiency Syndrome. N. Engl. J. Med. 323:1500-1504.
8. Roths, J.B., Marshall, J.D., Allen, R.D., Carlson, G.A., and Sidman, C.L. 1990. Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutants scid mice. Am. J. Pathol. 136:1173-1186.
9. Chen, W., Mills, J.W., and Harmsen, A.G. 1992. Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses. Int. J. Exp. Pathol. 73:709-720.
10. Wright, T.W., Johnston, C.J., Harmsen, A.G., and Finkelstein, J.N. 1997. Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice. Am. J. Respir. Cell Mol. Biol. 17:491-500.
11. Wright, T.W., Johnston, C.J., Harmsen, A.G., and Finkelstein, J.N. 1999. Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation. Infect. Immun. 67:3452-3460.
12. + cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172:937-945.
13. Shellito, J., et al. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Invest. 85:1686-1693.
14. Chen, W., Gigliotti, F., and Harmsen, A.G. 1993. Latency is not an inevitable outcome of infection with Pneumocystis carinii. Infect. Immun. 61:5406-5409.
15. Harmsen, A.G. 1988. Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation. Infect. Immun. 56:1858-1863.
16. Bergmann, K.C., Lachmann, B., and Noack, K. 1984. Lung mechanics in orally immunized mice after aerosolized exposure to influenza virus. Respiration. 46:218-221.
17. Amdur, M.O., and Mead, J. 1958. Mechanics of respiration in unanesthetized guinea pigs. Am. J. Physiol. 192:364-368.
18. Wiley, J.A., Geha, R., and Harmsen, A.G. 1997. Exogenous CD40 ligand induces a pulmonary inflammation response. J. Immunol. 158:2932-2938.
19. + lymphocytes in host defense against Pneumocystis carinii in mice. J. Lab. Clin. Med. 128:477-487.
20. Shanley, T.P., Warner, R.L., and Ward, P.A. 1995. The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol. Med. Today. 1:40-45.
21. Agostini, C., and Semenzato, G. 1996. Immunology of idiopathic pulmonary fibrosis. Curr. Opin. Pulm. Med. 2:364-369.
22. Driscoll, K.E., Carter, J.M., Hassenbein, D.G., and Howard, B. 1997. Cytokines and particle-induced inflammatory cell recruitment. Environ. Health Perspect. 105(Suppl. 5):1159-1164.
23. Ward, P.A., and Hunninghake, G.W. 1998. Lung inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 157:S123-S129.
24. + T cells into severe combined immunodeficiency mice. J. Clin. Invest. 90:673-678.
25. Varthalitis, I., and Meunier, F. 1993. Pneumocystis carinii pneumonia in cancer patients. Cancer Treat. Rev. 19:387-413.
26. Sanyal, S.K., et al. 1981. Course of pulmonary dysfunction in children surviving Pneumocytis carinii pneumonitis. Am. Rev. Respir. Dis. 124:161-166.
27. 67Ga scintigraphy in experimental Pneumocystis carinii pneumonia. Br. J. Exp. Pathol. 67:383-393.
28. Beck, J.M., et al. 1991. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am. J. Respir. Cell Mol. Biol. 5:186-197.
29. + T cells. J. Immunol. 162:2890-2894.